Villalobo Antonio
Cancer and Human Molecular Genetics Area-Oto-Neurosurgery Research Group, University Hospital La Paz Research Institute (IdiPAZ), Paseo de la Castellana 261, E-28046 Madrid, Spain.
Biomedicines. 2023 Feb 22;11(3):661. doi: 10.3390/biomedicines11030661.
Overexpression and mutations of the epidermal growth factor receptor (EGFR/ErbB1/HER1) and other tyrosine kinase receptors of the ErbB family (ErbB2/HER2, ErbB3/HER3 and ErbB4/HER4) play an essential role in enhancing the proliferation, the migratory capacity and invasiveness of many tumor cells, leading to cancer progression and increased malignancy. To understand these cellular processes in detail is essential to understand at a molecular level the signaling pathways and regulatory mechanisms controlling these receptors. In this regard, calmodulin (CaM) is a Ca-sensor protein that directly interacts with and regulates ErbB receptors, as well as some CaM-dependent kinases that also regulate these receptors, particularly EGFR and ErbB2, adding an additional layer of CaM-dependent regulation to this system. In this short review, an update of recent advances in this area is presented, covering the direct action of Ca/CaM on the four ErbB family members mostly in tumor cells and the indirect action of Ca/CaM on the receptors via CaM-regulated kinases. It is expected that further understanding of the CaM-dependent mechanisms regulating the ErbB receptors in future studies could identify new therapeutic targets in these systems that could help to control or delay cancer progression.
表皮生长因子受体(EGFR/ErbB1/HER1)及ErbB家族其他酪氨酸激酶受体(ErbB2/HER2、ErbB3/HER3和ErbB4/HER4)的过表达和突变在增强许多肿瘤细胞的增殖、迁移能力及侵袭性方面发挥着重要作用,进而导致癌症进展和恶性程度增加。详细了解这些细胞过程对于从分子水平理解控制这些受体的信号通路和调节机制至关重要。在这方面,钙调蛋白(CaM)是一种钙传感蛋白,它直接与ErbB受体相互作用并对其进行调节,同时一些钙调蛋白依赖性激酶也对这些受体进行调节,尤其是EGFR和ErbB2,为该系统增添了另一层钙调蛋白依赖性调节。在这篇简短的综述中,介绍了该领域的最新进展,涵盖了Ca/CaM主要在肿瘤细胞中对四种ErbB家族成员的直接作用以及Ca/CaM通过钙调蛋白调节激酶对受体的间接作用。预计在未来的研究中进一步了解调节ErbB受体的钙调蛋白依赖性机制能够确定这些系统中的新治疗靶点,从而有助于控制或延缓癌症进展。